Cutaneous lymphocyte antigen-positive T cells may predict the development of acute GVHD: Alterations and differences of CLA+ T- and NK-cell fractions

Bone Marrow Transplantation

Volumn 43, Issue 11, 2009, Pages 863-873

  Tsuchiyama, J ^a,b   Yoshino, T ^c   Saito, T ^c   Furukawa, T ^a   Ito, K ^a   Fuse, I ^a   Aizawa, Y ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CUTANEOUS LYMPHOCYTE ASSOCIATED ANTIGEN; CYCLOSPORIN A; D DIMER; FIBRIN; FIBRINOGEN; GAMMA INTERFERON; INTERLEUKIN 2; METHOTREXATE; TACROLIMUS;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; CELL FRACTIONATION; CHILD; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FEVER; FIBRIN METABOLISM; FIBRINOGEN METABOLISM; HUMAN; HUMAN CELL; LYMPHOCYTE COUNT; MALE; MYELODYSPLASTIC SYNDROME; NATURAL KILLER CELL; NATURAL KILLER CELL PERCENTAGE; NONHODGKIN LYMPHOMA; OXYGEN SATURATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PREDICTION; PRIORITY JOURNAL; SCHOOL CHILD; T LYMPHOCYTE; T LYMPHOCYTE PERCENTAGE;

ACUTE DISEASE; ADOLESCENT; ADULT; CELLS, CULTURED; CHILD; CYTOKINES; FEMALE; GRAFT VS HOST DISEASE; HUMANS; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; STEM CELL TRANSPLANTATION; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 67549133159     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.392     Document Type: Article

References (42)

1. Sullivan KM. Graft-vs-Host Disease. In: Blume KG, Fornman SJ, Applebaum FR (eds). Thomas' Hematopoietic Cell Transplantation, 3rd edn. Blackwell: Oxford, 2004, pp 635-664.
2. Ferrara JLM, Deeg HJ. Graft versus host disease. N Engl J Med 1991; 324: 667-674.
3. Goker H, Haznedaroglu IC, Chao NJ. Acute graft-vs-host disease: pathobiology and management. Exp Hematol 2001; 29: 259-277.
4. Ferrara JL. Pathogenesis of acute graft-versus-host disease: Cytokines and cellular effectors. J Hematother Stem Cell Res 2000; 9: 299-306.
5. Hill GR, Crawford GM, Cooke KR, Brinson YS, Pan L, Ferrara JL. Total body irradiation and acute graft-versus-host disease: The role of gastrointestinal damage and inflammatory cytokines. Blood 1997; 90: 3204-3213.
6. Ferrara JL, Cooke KR, Teshima T. The pathophysiology of acute graft-versus-host disease. Int J Hematol 2003; 78: 181-187.
7. Nestel F, Kichian K, You-Ten K, Desbarats J, Price K, Lapp W et al The role of endotoxin in the pathogenesis of acute graft-versus-host disease. In: Ferrara JL, Deeg HJ, Burakoff SJ (eds). Graft-vs-Host Disease, 2nd edn. Marcel Dekker Inc.: New York, 1996, pp 513-516.
8. Butcher EC, Williams M, Youngman K, Rott L, Briskin M. Lymphocyte trafficking and regional immunity. Adv Immunol 1999; 72: 209-253.
9. Campbell DJ, Butcher EC. Rapid acquisition of tissue specific homing phenotypes by CD4(+) T cell activated in cutaneous or mucosal lymphoid tissue. J Exp Med 2002; 195: 135-141.
10. Picker LJ, Treer JR, Ferguson-Darnell B, Collins PA, Bergstresser PR, Terstappen LW. Control of lymphocyte recirculation in man. II. Differential regulation of the cutaneous lymphocyte-associated antigen, a tissue-selective homing receptor for skin-homing T cells. J Immunol 1993; 150: 1122-1136.
11. Fuhlbrigge RC, Kieffer JD, Armerding D, Kupper TS. Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells. Nature 1997; 389: 978-981.
12. Berg EL, Yoshino T, Rott LS, Robinson MK, Warnock RA, Kishimoto TK et al. The cutaneous lymphocyte antigen is a skin lymphocyte homing receptor for the vascular lectin endothelial cell-leukocyte adhesion molecule 1. J Exp Med 1991; 174: 1461-1466.
13. Leung DY, Gately M, Trumble A, Ferguson-Darnell B, Schlievert PM, Picker LJ. Bacterial superantigens induce T cell expression of the skin selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of interleukin 12 production. J Exp Med 1995; 181: 747-753.
14. Tsuchiyama J, Yoshino T, Toba K, Harada N, Nishiuchi R, Akagi T et al Induction and characterization of cutaneous lymphocyte antigen (CLA) on natural killer cells. Br J Hematol 2002; 118: 654-662.
15. Faaij CM, Lankester AC, Spierings E, Hoogeboom M, Bowman EP, Bierings M et al. A possible role for CCL27/CTACK-CCR10 interaction in recruiting CD4+ T cells in human graft-versus-host disease. Br J Hematol 2006; 133: 538-549.
16. Scharf SJ, Smith AG, Hansen JA, McFarland C, Erlich HA. Quantitative determination of bone marrow transplant engraftment using fluorescent polymerase chain reaction primers for human identity markers. Blood 1995; 85: 1954-1963.
17. Andrew DP, Ruffing N, Kim CH, Miao W, Heath H, Li Y et al. C-C chemokine receptor 4 expression defines a major subset of circulating nonintestinal memory T cells of both Th1 and Th2 potential. J Immunol 2001; 166: 103-111.
18. Farrell AM, Antrobus P, Simpson D, Powell S, Chapel HM, Ferry BL. A rapid flow cytometric assay to detect CD4+ and CD8+ T-helper (Th) 0, Th1 and Th2 cells in whole blood and its application to study cytokine levels in atopic dermatitis before and after cyclosporin therapy. Br J Dermatol 2001; 144: 24-33.
19. Ohara T, Koyama K, Kusunoki Y, Hayashi T, Tsuyama N, Kubo Y et al. Memory functions and death proneness in three CD4+CD45RO+ human T cell subsets. J Immunol 2002; 169: 39-48.
20. Beilhack A, Schultz S, Baker J, Beilhack FG, Nihsimura R, Baker EM et al. Prevention of acute graft-versus-host disease by blocking T-cell entry to secondary lymphoid organs. Blood 2008; 111: 2919-2928.
21. Anasetti C, Velardi A. Hematopoietic cell transplantation from HLA partially matched related donors. In: Blume KG, Fornman SJ, Applebaum FR (eds). Thomas' Hematopoietic cell transplantation, 3rd edn. Blackwell: Oxford, 2004, pp 1116-1131.
22. + cells through IL-12 produced by Listeria-induced macrophages. Science 1993; 260: 547-549.
23. Scott P. IL-12: Initiation cytokine for cell mediated immunity. Science 1993; 260: 496-497.
24. Rosenstein M, Ettinghasusen SE, Rosenberg SA. Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin 2. J Immunol 1986; 137: 1735-1742.
25. Thompson JA, Cox WW, Lindgren CG, Collins C, Neraas KA, Bonnem EM et al. Subcutaneous gamma interferon in cancer patients: Toxicity, pharmacokinetics, and immunomodulatory effects. Cancer Immunol Immunother 1987; 25: 47-53.
26. Mahmoud HH, Pui CH, Kennedy W, Jaffe HS, Crist WM, Murphy SB. Phase 1 study of recombinant human interferon gamma in children with relapsed acute leukemia. Leukemia 1992; 6: 1181-1191.
27. Petrovic A, Alpdogan O, Willis LM, Eng JM, Greenberg AS, Kappel BJ et al. LPAM (α4β7 integrin) is an important homing integrin on alloreactive T cells in the development of intestinal graft-versus-host disease. Blood 2004; 103: 1542-1547.
28. Stacey N, Cox J, Loblay R, Crosbie J. Neuraminidase pretreatment of donor lymphocytes and graft-versus-host disease. Exp Hematol 1989; 17: 273-277.
29. Haddad W, Cooper C J, Zhang Z, Brown JB, Zhu Y, Issekutz A et al. P-selectin and P-selectin glycoprotein ligand 1 are major determinants for Th1 cell recruitment to Nonlymphoid effector sites in the intestinal lamina propria. J Exp Med 2003; 198: 369-377.
30. Schuyser E, Struyf S, Damme JV. The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev 2003; 14: 409-426.
31. Sugita S, Kohno T, Yamamoto K, Imaizumi Y, Nakajima H, Ishimaru T et al. Induction of macrophage-inflammatory protein 3 gene expression by TNF-α dependent NF-κB activation. J Immunol 2002; 168: 5621-5628.
32. Lukacs NW, Prosser DM, Wiekowski M, Lira SA, Cook DN. Requirement for the chemokine receptor CCR6 in allergic pulmonary inflammation. J Exp Med 2001; 194: 551-555.
33. Saeki H, Tamaki K. Thymus and activation regulated chemokine (TARC)/ CCL17 and skin diseases. J Dermatol Sci 2006; 43: 75-84.
34. Horikawa T, Nakayama T, Hikita I, Yamada H, Fujisawa R, Bito T et al IFN-gamma-inducible expression of thymus and activation-regulated chemokine/CCL17 and macrophage-derived chemokine/CCL22 in epidermal keratinocytes and their roles in atopic dermatitis. Int Immunol 2002; 14: 767-773.
35. Berin MC, Eckmann L, Broide DH, Kagnoff MF. Regulated production of the T helper 2-type T-cell chemoattractant TARC by human bronchial epithelial cells in vitro and in human lung xenografts. Am J Respir Cell Mol Biol 2001; 24: 382-389.
36. Yamashita U, Kuroda E. Regulation of macrophage-derived chemokine (MDC, CCL22) production. Crit Rev Immunol 2002; 22: 105-114.
37. Lloyd CM, Rankin SM. Chemokines in allergic airway disease. Curr Opin Pharmacol 2003; 3: 443-447.
38. Terada N, Nomura T, Kim WJ, Otsuka Y, Takahashi R, Yamashita T et al Expression of C-C chemokine TARC in human nasal mucosa and its regulation by cytokines. Clin Exp Allergy 2001; 12: 1923-1931.
39. Nasu K, Sun B, Nishida M, Fukuda J, Narahara H, Miyakawa I. Cultured human endometrial epithelial cells produce thymus and activation-regulated chemokine with stimulation of interleukin-4 and interleukin-13. Fertil Steril 2004; 82: 1014-1018.
40. Fukuda K, Fujitsu Y, Seki K, Kumagai N, Nishida T. Differential expression of thymus- and activation-regulated chemokine (CCL17) and macrophage-derived chemokine (CCL22) by human fibroblasts from cornea, skin, and lung. J Allergy Clin Immunol 2003; 111: 520-526.
41. Mutis T, Gillespie G, Schrama E, Falkenburg JH, Moss P, Goulmy E. Tetrameric HLA class 1-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility anitgen-specific cytotoxic T lymphoctes in patients with graft-versus-host disease. Nat Med 1999; 5: 839-842.
42. Dickinson AM, Wang XN, Sviland L, Vyth-Dreese FA, Jackson GH, Schumacher TN et al. In situ dissection of the graft-versus-host activities of cytotoxic T-cells specific for minor histocompatibility antigens. Nat Med 2002; 8: 410-414.